Back to today’s briefing

Story perspectives

Ozempic Approved to Fight Kidney Disease and Heart Risk

2/6/2025

43 3

Summary

Story summary

Novo Nordisk's Ozempic has gained FDA approval to combat the progression of chronic kidney disease (CKD) and reduce the risk of cardiovascular death in adults with Type 2 diabetes and CKD. This pivotal approval broadens its application, offering hope to millions grappling with these serious health challenges across the U.S.

1 of 1

Story summary

Novo Nordisk's Ozempic has gained FDA approval to combat the progression of chronic kidney disease (CKD) and reduce the risk of cardiovascular death in adults with Type 2 diabetes and CKD. This pivotal approval broadens its application, offering hope to millions grappling with these serious health challenges across the U.S.